Article
Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.
Neuron - 21 Jul 2005
McGowan Eileen, Pickford Fiona, Kim Jungsu, Onstead Luisa, Eriksen Jason, Yu Cindy, Skipper Lisa, Murphy M Paul, Beard Jenny, Das Pritam, Jansen Karen, DeLucia Michael, Lin Wen-Lang, Dolios Georgia, Wang Rong, Eckman Christopher B, Dickson Dennis W, Hutton Mike, Hardy John, Golde Todd
Abstract excerpt
Considerable circumstantial evidence suggests that Abeta42 is the initiating molecule in Alzheimer's disease (AD) pathogenesis. However, the absolute requirement for Abeta42 for amyloid deposition has never been demonstrated in vivo. We have addressed this by developing transgenic models that express Abeta1-40 or Abeta1-42 in the absence of human amyloid beta protein precursor (APP) overexpression. Mice...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
